John Lauerman, Bloomberg News
John Lauerman is a reporter-at-large at Bloomberg News writing about health and higher education. Lauerman and his colleagues won a Polk Award and were Pulitzer finalists in 2011 for a series of stories on for-profit colleges that recruit low-income students, often to leave them with debt and no degree. The series also won a Gerald Loeb Award, a National Headliner Award, and the Education Writers Association Grand Prize. In 2010, he won a New York Press Club award for coverage of Harvard University’s $1 billion loss on risky investments. He won a 2009 award from the Society of the Silurians for his stories on the failed search for a vaccine against HIV. His team won a 2005 award from the Society of American Business Writers and Editors for coverage of Merck & Co.’s withdrawal of the painkiller Vioxx after it was linked to heart disease. He has been a fellow of the Blue Cross Blue Shield of Massachusetts Health Coverage program and the Kaiser Family Foundation’s program for science journalists.
Before coming to Bloomberg, Lauerman was a science writer at Harvard Medical School from 1985 through 1988. Later, as a freelance journalist, he wrote a health column for Harvard Magazine, contributed to newspapers and magazines across the United States, and edited the public health journal Health and Human Rights. He is the co-author of two books: “Diabetes: Understand Your Condition, Make the Right Treatment Choices, and Cope Effectively,” and “Living to 100.” He lives with his wife and two children in Brookline, Massachusetts.